跳至主要内容
临床试验/NL-OMON51366
NL-OMON51366尚未招募不适用

Evaluating the use of Magnetic Resonance Imaging and Contrast Enhanced Mammography after MagTrace® use - MagTrace 2

Zuyderland Medisch Centrum0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Female patients of 18 years and older.
  • - Previously underwent breast conserving surgery and sentinel lymph node biopsy
  • using MagTrace®.
  • - Undergoing standard follow-up for previous breast cancer

排除标准

  • - Unable to comprehend the extend and implications of the study and sign for
  • informed consent.
  • - Standard MRI exclusion criteria:
  • o Implantable (electrical) devices (e.g., pacemaker, cochlear implants,
  • neurostimulator);
  • o Any other metal implants;
  • o Claustrophobia;
  • o MR-incompatible prosthetic heart valves.
  • - Standard CEM exclusion criteria:
  • o Breast implants.
  • NB: since no contrast will be used during the CEM, standard contrast
  • contraindications were not included as exclusion criteria for this trial.

研究者

发起方
Zuyderland Medisch Centrum

相似试验

Evaluating the use of Magnetic Resonance Imaging and... | 临床试验